Target intelligence / Profile preview

Innate and adaptive immune system – non-specific

Molecular classification
Other
01

Overview

The innate and adaptive immune systems represent the two primary arms of the vertebrate host defense mechanism, working in concert to protect the organism from pathogens and internal threats like cancer [1]. The innate immune system provides an immediate, non-specific response through physical barriers, phagocytic cells (such as macrophages and neutrophils), and the complement system [2]. In contrast, the adaptive immune system provides a highly specific response mediated by B and T lymphocytes, which recognize unique antigens and establish long-term immunological memory [3]. While these systems are vital for survival, their dysregulation is a hallmark of numerous pathologies, including chronic inflammatory diseases and autoimmune disorders [1, 2]. Because the term Innate and adaptive immune system – non-specific refers to a vast network of cells, tissues, and molecular pathways rather than a single protein or receptor, it is not considered a discrete therapeutic target in drug discovery [3]. Instead, pharmacological agents are designed to target specific components within these systems, such as individual cytokines or cell-surface receptors, to achieve precise therapeutic effects.

Other names
Immune systemHost defense systemInnate immunityAdaptive immunityImmune response
02

Mechanism of action

Broad immunomodulation, including systemic immunosuppression or non-specific immunostimulation, affecting multiple cell types and signaling pathways simultaneously.

03

Biological functions

Immune responseHost defenseInflammationPathogen recognitionAntigen presentationImmunological memoryCellular homeostasis
04

Disease associations

InfectionAutoimmune diseaseCancerInflammationImmunodeficiencyHypersensitivity
05

Safety considerations

Increased susceptibility to opportunistic infectionsImpaired wound healingRisk of secondary malignanciesCytokine release syndromeSystemic toxicity
06

Interacting drugs

Corticosteroids (e.g., Prednisone)

5 more in the full profile.

07

Biomarkers

White blood cell (WBC) countC-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Cytokine levels (e.g., IL-6, TNF-alpha)Absolute lymphocyte count

Beyond the preview

Go deeper on Innate and adaptive immune system – non-specific.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate and adaptive immune system – non-specific.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call